SCHEMBL7590923

SCHEMBL7590923

CCCC(CCC)n1nnc2c(Nc3c(C)cc(C)nc3C)nc(C)nc21

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 15/20 0.43
TSHR P16473 1/20 0.37
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474332 0.96 CRHR1 (0.42) CRHR1TSHRLMNA
SCHEMBL7538831 0.88 CRHR1 (0.54) CRHR1
SCHEMBL7483912 0.85 CRHR1 (0.51) CRHR1LMNA
SCHEMBL8194048 0.83 CRHR1 (0.52) CRHR1
SCHEMBL7625566 0.83 CRHR1 (0.49) CRHR1
SCHEMBL7480702 0.78 CRHR1 (0.52) CRHR1
SCHEMBL7539896 0.77 CRHR1 (0.50) CRHR1LMNA
SCHEMBL7621616 0.75 CRHR1 (0.47) CRHR1TSHR
SCHEMBL8202018 0.73 CRHR1 (0.56) CRHR1
SCHEMBL27500001 0.73 CRHR1 (0.48) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0935601-A4 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARM CO (US) 2002-08-07 EP claimed
EP-0935601-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES Du Pont Pharmaceuticals Company (US) 1999-08-18 EP claimed
WO-1997035539-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO claimed
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
US-6107300-A CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS (US) 2000-08-22 US disclosed